Biotech Values

[vinmantoo]

Thanks dewophile.

In the Phase 2b B-Clear study (209668), bepirovirsen (BPV; an antisense oligonucleotide) 300 mg for 24 weeks (wks) achieved sustained HBsAg and HBV DNA loss (

Looks like duration for some patients isn't very good. They should be told to use a different approach. Perhaps a call to ENTA would help.